Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.2600
-0.1300 (-5.44%)
NASDAQ· Last Trade: Sep 15th, 2:45 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors